| |
| |
|
| Insider
Information: |
Manhard Kimberly |
| Relationship: |
EVP, Drug Development |
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,330 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$108,221 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,330 |
|
|
| Total
Value |
$108,221 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
SVP, Regulatory & Dev ... |
2012-06-19 |
0 |
2009-05-19 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
EVP, Drug Development |
2023-04-13 |
28,330 |
2015-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-09-28 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,387 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-10-28 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,387 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-11-28 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-12-28 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-01-30 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-02-28 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-03-28 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-04-30 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-05-29 |
4 |
OE |
$3.90 |
$19,500 |
D/D |
5,000 |
14,970 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2019-04-30 |
4 |
A |
$18.43 |
$20,437 |
D/D |
1,109 |
1,109 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2019-05-01 |
4 |
AS |
$18.86 |
$20,918 |
D/D |
(1,109) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-04-30 |
4 |
A |
$13.90 |
$21,249 |
D/D |
1,529 |
3,163 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2015-06-01 |
4 |
OE |
$9.05 |
$24,507 |
D/D |
2,708 |
2,708 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-05-03 |
4 |
AS |
$17.66 |
$27,009 |
D/D |
(1,529) |
1,634 |
0 |
% |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2009-10-28 |
4 |
AS |
$14.20 |
$35,508 |
D/D |
(2,500) |
6,413 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-02-26 |
4 |
AS |
$14.28 |
$35,709 |
D/D |
(2,500) |
7,325 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2009-11-27 |
4 |
AS |
$14.44 |
$36,097 |
D/D |
(2,500) |
7,325 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2009-12-28 |
4 |
AS |
$14.49 |
$36,225 |
D/D |
(2,500) |
7,325 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-01-28 |
4 |
AS |
$14.54 |
$36,350 |
D/D |
(2,500) |
7,325 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-03-29 |
4 |
AS |
$18.72 |
$46,790 |
D/D |
(2,500) |
7,325 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Operations |
• – – |
2009-09-28 |
4 |
AS |
$19.10 |
$47,743 |
D/D |
(2,500) |
6,413 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-07-28 |
4 |
AS |
$19.44 |
$48,600 |
D/D |
(2,500) |
7,668 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-06-28 |
4 |
AS |
$21.92 |
$54,809 |
D/D |
(2,500) |
7,668 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2015-06-01 |
4 |
S |
$21.17 |
$57,328 |
D/D |
(2,708) |
0 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-05-28 |
4 |
AS |
$24.91 |
$62,423 |
D/D |
(2,500) |
7,668 |
0 |
- |
|
119 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
